ArticleHeliyon2022

First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency.

Masayuki Aso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.